Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Hair loss may increase heart disease risk.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

A male with aromatase deficiency improved bone health with estradiol treatment.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.